The objective of this project is to improve the understanding, diagnosis, and treatment of dry eye disorders, including those associated with decreased tear secretion (eg, lacrimal gland disease and neurotrophic keratitis) and increased tear film evaporation (eg, meibomian gland dysfunction). The proposed protocols specifically will test the following hypotheses in the rabbit models that now exist for these dry eye disorders: 1) In keratoconjunctivitis sicca (KCS), the progression of ocular surface disease can be halted or reversed by treatment with aqueous electrolyte solutions, or by administration of topically active tear secretagogues. 2) In meibomitis, surface disease can be improved by fluid supplementation and treatment of the inflammatory process centered in and around the meibomian glands. 3) In neurotrophic keratitis, surface disease can be improved by fluid supplementation. 4) Rabbits with simultaneous KCS, meibomitis, and neurotrophic keratitis will show epithelial healing abnormalities and perhaps persistent epithelial defects. These defects will heal by using a combination of the separate treatments for these dry eye disorders. 5) Elevated tear osmolarity in dry eye disorders is associated with abnormalities in tear electrolyte composition, and these must be corrected to attain optimum surface haling. In these rabbit models, the natural history of ocular disease over 20 weeks has been or will be mapped, studying tear osmolarity, tear electrolyte composition, ocular surface morphology, corneal epithelial glycogen, and conjunctival goblet-cell density. To determine the effect of treatment on the natural history of disease, rabbits will be treated from 12 to 20 weeks postoperatively. Tear electrolytes will be measured in tear microvolumes using flameless atomic absorption spectrophotometry. To supplement tear fluid in these diseases, electrolyte solutions will be applied by continuous infusion with infusaid pumps, or tear secretion will be stimulated pharmacologically by topically applied secretagogues. To treat inflammation, tetracyclines will be used, as well as other agents that potentially might decrease inflammation or collagenase activity. Based on the data obtained from the rabbit models for KCS, parallel studies will be performed in patients with KCS to test the therapeutic efficacy in humans of agents found to be therapeutic in our rabbit models.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY003373-09
Application #
3257700
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1980-07-01
Project End
1993-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
9
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Schepens Eye Research Institute
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114
Gilbard, J P (1994) Human tear film electrolyte concentrations in health and dry-eye disease. Int Ophthalmol Clin 34:27-36
Gilbard, J P; Rossi, S R (1994) Changes in tear ion concentrations in dry-eye disorders. Adv Exp Med Biol 350:529-33
Gilbard, J P; Rossi, S R (1994) A unique therapeutic artificial tear formulation. Adv Exp Med Biol 350:465-9
Gilbard, J P (1994) Treatment of keratoconjunctivitis sicca in rabbits with 3-isobutyl-1-methylxanthine. Arch Ophthalmol 112:1614-6
Gilbard, J P; Cohen, G R; Baum, J (1992) Decreased tear osmolarity and absence of the inferior marginal tear strip after sleep. Cornea 11:231-3
Gilbard, J P; Rossi, S R (1992) An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca. Ophthalmology 99:600-4
Gilbard, J P; Cohen, G R; Baum, J (1991) Decreased tear osmolarity and absence of the inferior marginal tear strip following sleep. Trans Am Ophthalmol Soc 89:209-13;discussion 213-4
Gilbard, J P; Rossi, S R; Heyda, K G et al. (1991) Stimulation of tear secretion and treatment of dry-eye disease with 3-isobutyl-1-methylxanthine. Arch Ophthalmol 109:672-6
Rossi, S R; Dartt, D A; Gilbard, J P (1990) Eledoisin and lacrimal secretion in the rabbit. Curr Eye Res 9:273-6
Gilbard, J P; Rossi, S R (1990) Tear film and ocular surface changes in a rabbit model of neurotrophic keratitis. Ophthalmology 97:308-12

Showing the most recent 10 out of 25 publications